CVRxCVRX -13.47%62 Buyback Yield % is 0.17 as of Jun. 30, 2026. GuruFocus rates CVRX with a GF Score™ of 62/100 and a GF Value™ of $11.22 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 345 Medical Devices & Instruments companies, CVRx ranks better than 69.86% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for CVRx's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVRX vs OWLT, HYPR, MXCT: Buyback Yield % Comparison
For the Medical Devices subindustry, CVRx's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVRx Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CVRx's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where CVRx's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVRx (CVRX) has a Buyback Yield % of 0.17 as of Jun. 30, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CVRx and its competitors. According to the industry distribution chart, CVRx ranks #104 out of 345 companies in the Medical Devices & Instruments industry, placing it in the top 30.1%.
Is CVRx's Buyback Yield % too high?
CVRx's current Buyback Yield % is 0.17. Based on the distribution chart, CVRx ranks #104 out of 345 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, CVRx has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CVRx's Buyback Yield % compare to OWLT and HYPR?
According to the Medical Devices & Instruments industry distribution chart, CVRx ranks #104 out of 345 companies for Buyback Yield %. This puts CVRx in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CVRx and its competitors. CVRx's current Buyback Yield % is 0.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVRx stock overvalued right now?
Based on GuruFocus' analysis, CVRx (CVRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.22, compared to a current price of $5.14 — trading 54.2% below its estimated fair value. The current Buyback Yield % is 0.17. CVRx's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For CVRx (CVRX), the current Buyback Yield % is 0.17 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVRx (CVRX) Overvalued in 2026?
Based on GuruFocus' analysis, CVRx stock appears to be undervalued.
The current stock price of $5.14 is trading 54.2% below its estimated GF Value™ of $11.22.
GuruFocus considers CVRx to be Possible Value Trap.
Key valuation signals for CVRX:
Buyback Yield %: 0.17
GF Value™: $11.22 vs. price of $5.14 (54.2% below fair value)
No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
62GF Score
Get the complete analysis for CVRX
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVRX has been successfully added to your 
